Literature DB >> 21600833

Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.

Gaurav Goel1, Pramod Kumar Pal, Shivashankar Ravishankar, Ganesan Venkatasubramanian, Peruvumba N Jayakumar, Nithin Krishna, Meera Purushottam, Jitender Saini, Mohammed Faruq, Mitali Mukherji, Sanjeev Jain.   

Abstract

INTRODUCTION: Spinocerebellar ataxias (SCA) are a group of autosomal dominant ataxias with varied clinical phenotypes. However there are no unique distinguishing features on routine neuroimaging among the various genetically defined SCAs. Voxel-based morphometry (VBM) provides an automated unbiased analysis of structural MRI scans and gives a comprehensive assessment of anatomical differences throughout the brain.
OBJECTIVES: The aims of this study were to (i) characterize the patterns of atrophy in SCA1, SCA2 and SCA3 using optimized VBM, (ii) demonstrate the characteristic anatomical differences in these genetically distinct SCA subtypes, and (iii) assess the relationship between morphometric measures and the CAG repeat lengths and other attributes of the disease.
METHODS: Thirty-one genetically confirmed patients suffering from SCA (SCA1 - 12, SCA2 - 9, and SCA3 - 10) were studied. High resolution T1-weighted 3-Dimensional Magnetic Resonance Images of 31 patients were analyzed using the optimized VBM procedure.
RESULTS: In all the three SCAs there was a significant loss of gray matter in both cerebellar hemispheres and vermis. Vermian atrophy was more pronounced in SCA3, while SCA1 and SCA2 had significant white matter atrophy. Pontine white matter atrophy was more pronounced in SCA2. In SCA1, the severity of ataxia strongly correlated with the degree of gray matter atrophy in cerebellar hemispheres. The duration of symptoms and lengths of CAG repeats had no correlation with the degree of atrophy.
CONCLUSIONS: This study showed that the different subtypes of SCAs may have morphometric differences in the cerebellum, brainstem and the supratentorial structures.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21600833     DOI: 10.1016/j.parkreldis.2011.04.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  21 in total

1.  Spinocerebellar ataxia type 2 neurodegeneration differentially affects error-based and strategic-based visuomotor learning.

Authors:  Israel Vaca-Palomares; Rosalinda Díaz; Roberto Rodríguez-Labrada; Jacqeline Medrano-Montero; Yaimé Vázquez-Mojena; Luis Velázquez-Pérez; Juan Fernandez-Ruiz
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

2.  Impact of cerebellar atrophy on cortical gray matter and cerebellar peduncles as assessed by voxel-based morphometry and high angular resolution diffusion imaging.

Authors:  Michael Dayan; G Olivito; M Molinari; Mara Cercignani; Marco Bozzali; M Leggio
Journal:  Funct Neurol       Date:  2016 Oct/Dec

3.  Paradigm for disease deconvolution in rare neurodegenerative disorders in Indian population: insights from studies in cerebellar ataxias.

Authors:  Renu Kumari; Deepak Kumar; Samir K Brahmachari; Achal K Srivastava; Mohammed Faruq; Mitali Mukerji
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.

Authors:  M Mascalchi; N Toschi; M Giannelli; A Ginestroni; R Della Nave; E Nicolai; A Bianchi; C Tessa; E Salvatore; M Aiello; A Soricelli; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-16       Impact factor: 3.825

Review 5.  Current molecular insight to reveal the dynamics of CAG repeating units in spinocerebellar ataxia.

Authors:  Priyanka Vishwakarma; Srinivasan Muthuswamy; Sarita Agarwal
Journal:  Intractable Rare Dis Res       Date:  2018-05

Review 6.  Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

Authors:  Meng-Ling Chen; Chih-Chun Lin; Liana S Rosenthal; Puneet Opal; Sheng-Han Kuo
Journal:  J Neurol Sci       Date:  2021-04-01       Impact factor: 3.181

Review 7.  Spinocerebellar ataxia clinical trials: opportunities and challenges.

Authors:  Sarah M Brooker; Chandrakanth Reddy Edamakanti; Sara M Akasha; Sheng-Han Kuo; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2021-05-21       Impact factor: 4.511

8.  Social and Cultural Elements Associated with Neurocognitive Dysfunctions in Spinocerebellar Ataxia Type 2 Patients.

Authors:  Roberto Emmanuele Mercadillo; Víctor Galvez; Rosalinda Díaz; Lorena Paredes; Javier Velázquez-Moctezuma; Carlos R Hernandez-Castillo; Juan Fernandez-Ruiz
Journal:  Front Psychiatry       Date:  2015-06-10       Impact factor: 4.157

9.  Spinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers.

Authors:  Anna Nigri; Lidia Sarro; Alessia Mongelli; Anna Castaldo; Luca Porcu; Chiara Pinardi; Marina Grisoli; Stefania Ferraro; Laura Canafoglia; Elisa Visani; Maria Grazia Bruzzone; Lorenzo Nanetti; Franco Taroni; Caterina Mariotti
Journal:  Cerebellum       Date:  2021-06-09       Impact factor: 3.847

10.  In vivo microstructural white matter changes in early spinocerebellar ataxia 2.

Authors:  Albert Stezin; Sujas Bhardwaj; Sunil Khokhar; Shantala Hegde; Sanjeev Jain; Rose Dawn Bharath; Jitender Saini; Pramod Kumar Pal
Journal:  Acta Neurol Scand       Date:  2020-11-04       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.